The article “Health economics and vaccine financing in the Eastern Mediterranean Region: A needs assessment,” published in Vaccine by Elsevier, provides a comprehensive analysis of how health economics and financing are being applied in immunization programmes across...
Spain’s first pilot integrating economic evaluations into drug reimbursement decisions reveals progress, challenges, and lessons for the future. This study by Laura Vallejo-Torres, Juan Oliva-Moreno, and Félix Lobo examines how economic evaluations (EEs) were...
In their article published in Health Economics, Policy and Law by Cambridge University Press, Filippos Papadopoulos, Erica Visintin, Ilias Kyriopoulos, and Panos Kanavos explore the reasons why certain drugs fail health technology assessments (HTAs) across seven OECD...
This 2024 article aims to characterize the status of Health Technology Assessment (HTA) in Algeria and describe the future directions for HTA implementation according to the priorities set by local stakeholders
The Department of Health (DoH) in Abu Dhabi has released comprehensive Health Technology Assessment (HTA) guidelines to guide the adoption, reimbursement, and governance of emerging health technologies. These guidelines aim to ensure that costly and innovative...
The study examines the development and spatio-temporal evolution of China's multi-level medical insurance system (MMIS) from 2011 to 2020, highlighting improvements in the coupling coordination index (CCI) which rose from a moderate disorder to a well-coordinated...
The global landscape of Health Technology Assessment (HTA) processes is evolving as countries strive to implement evidence-based decision-making for healthcare services. This survey, covering 104 countries, offers an insightful analysis of the current state of HTA...
The discovery of oil has enabled GCC countries to provide universal healthcare to their citizens, but rising healthcare demands pose challenges in financing these systems effectively. Experts in health economics from the Gulf Health Economics Association held a focus...
Improving health equity is vital for individual and societal well-being, as evidenced by significant disparities in life expectancy across England. The National Institute for Health and Care Excellence (NICE) emphasizes the importance of reducing health inequalities,...
Published in The Lancet Global Health, the study by Lachlan Oldfield, Jonathan Penm, Ardalan Mirzaei, and Rebekah Moles examines the prices, availability, and affordability of essential medicines in 54 low- and middle-income countries. Using a secondary analysis based...
In their 2025 study published in Health Economics, Policy and Law by Cambridge University Press, Juan Carlos Rejon-Parrilla, David Epstein, Daniel Pérez-Troncoso, and Jaime Espín explore how medicines reimbursement should be structured in Spain. While reimbursement...
As of January 12, 2025, the EU's Health Technology Assessment Regulation (EU 2021/2282) is officially in force, marking a significant step towards greater collaboration across 27+ countries in evaluating health technologies to improve healthcare decisions.The European...
Risk-sharing agreements (RSAs) have been introduced to allocate risk between payers and pharmaceutical companies, often taking the form of outcome-based or financial-based models. This study seeks to explore the perspectives of key stakeholders within Singapore’s...
Italy could save approximately €21.74 billion annually by using AI in healthcare, cutting costs by 10-15%. AI could automate up to 36% of tasks in the health and social sectors, allowing human resources to focus on higher-value activities and improving system...
The article titled "A Framework for Improved Collaboration on HTA in the Asia-Pacific Region: A Role for HTAsiaLink," published in the International Journal of Technology Assessment in Healthcare examines the crucial role of Health Technology Assessment (HTA) in...
